Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Accriva Diagnostics, Inc.

Accriva Diagnostics, Inc. Recalls

All product recalls associated with Accriva Diagnostics, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

249

Past Year

18

Class I (Serious)

5

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 249 recalls

Hemochron Activated Clotting Time Low-Range Test Cuvette,... (Accriva Diagnostics, Inc.) – foreign object (2025)

Test cuvettes, used with an assay for monitoring heparin anticoagulation, may have a foreign object that has sharp edges and could pose a risk of injury if not detected prior to handling.

FDANov 5, 2025Nationwide• Accriva Diagnostics, Inc.

VerifyNow PRUTest (Accriva) – Unauthorized Device Distribution (2025)

Due to an device without a premarket clearance being incorrectly package and distributed.

FDAOct 21, 2025Nationwide• Accriva Diagnostics, Inc.

Levothyroxine Tablets (Accord) – Subpotent Medication (2025)

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Previous

12 3...13

Page 1 of 13Next

Moderate

FDASep 16, 2025Nationwide• ACCORD HEALTHCARE, INC.

Accelera Omikron A/T Tire (ACCELERA) – Sidewall Separation (2025)

PT. Elangperdana Tyre Industry (EP Tyre) is recalling certain Accelera Omikron A/T tires, size LT265/65R18A. The sidewall may separate near the tire bead. As such, these tires fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 139, "New Pneumatic Radial Tires for Light Vehicles."

NHTSAJun 27, 2025Nationwide• ACCELERA

F-150 Trailer Brake Controller (FORD) – Brake Hydraulics (2025)

Ford Motor Company (Ford) is recalling certain Trailer Brake Controllers sold as accessory parts for 2021-2022 F-150 vehicles with part numbers ML3Z-19H332-AA, ML3Z-19H332-BA and ML3Z-19H332-CA. This recall includes vehicles equipped with the recalled accessory parts that were previously repaired incorrectly under recall 22E045. The trailer brake controllers may fail to apply the trailer brakes when towing a trailer equipped with an electric or electric-over-hydraulic brake system.

NHTSAJun 27, 2025Nationwide• FORD ACCESSORY PARTS

Levothyroxine Sodium Tablets 100mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 50mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 150mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 175mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 112mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 25mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets 25mcg (Accord) – Subpotent Drug (2025)

Subpotent Drug: Assay below the approved specification

Class IIModerate

FDAJun 20, 2025Nationwide• ACCORD HEALTHCARE, INC.

Sondiko Butane Torches (Wenzhou Wansheng) – fire hazard (2025)

This recall involves Sondiko Butane Torches with model number S400, sold in single and in two-packs. The brand name "Sondiko" is printed on the nozzle and the model number is on the head of the torch. They are black and silver in color.

CPSCApr 24, 2025Nationwide• Wenzhou Wansheng Smoking Accessories Co. Ltd., of China

Levothyroxine Sodium Tablets (Accord Healthcare) – Subpotent Medication (2025)

Subpotent

Class IIModerate

FDAApr 10, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine 50mcg (ACCORD) – Subpotent (2025)

Subpotent

Class IIModerate

FDAApr 10, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine 88mcg (ACCORD) – Subpotent (2025)

Subpotent

Class IIModerate

FDAApr 10, 2025Nationwide• ACCORD HEALTHCARE, INC.

Levothyroxine Sodium Tablets (Accord Healthcare) – Subpotent Medication (2025)

Subpotent

Class IIModerate

FDAApr 10, 2025Nationwide• ACCORD HEALTHCARE, INC.

PowerPICC Catheters (Bard) – tubing specification issue (2025)

Catheters indicated for short-or-long term access to the central venous system have tubing that exceeded melt flow index specification (higher), which could lead to increased material fatigue leaks, which could lead to infiltration, extravasation, discomfort, phlebitis, bleeding, air embolism, foreign body embolism, infection and interruption to therapy.

FDAMar 11, 2025Nationwide• Bard Access Systems, Inc.

CyberKnife Treatment System (Accuray) – Snap Ring Detachment (2024)

Snap rings may become partially or completed detached from the shafts within the internal mechanism. Uncontrolled rotation may occur on the left and right roll axes when the rings are removed or damaged.

FDADec 23, 2024Nationwide• Accuray Incorporated

VerifyNow P2Y12 Platelet Test (Accriva) – Market Clearance Issue (2024)

Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.

FDADec 2, 2024Nationwide• Accriva Diagnostics, Inc.